Cordonier et al identified risk factors for predicting mortality from invasive aspergillosis in a patient who has had a hematopoietic stem cell transplant. This can help identify a patient who may benefit from closer monitoring and more aggressive management. The authors are from multiple universities and hospitals in Paris, Strasbourg, Nantes and Villejuif in France.